News

The National Institute for Health and Care Excellence (NICE) has released new UK guidance which sets out how doctors should balance the risks of COVID-19 infection for patients needing radiotherapy or stem cell transplants. It is the second set of guidelines fast-tracked by NICE in response to the evolving COVID-19 global pandemic. In relation to stem cell transplants, the guidance states that most non-urgent allogenic stem cell transplant procedures should be deferred until the pandemic risks have been passed. This would include most patients with chronic blood cancers. For radiotherapy, the NICE guidance advises that radiotherapy should be avoided if it is likely to provide little or no benefit or if there is an alter...